Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China flag China · Delayed Price · Currency is CNY
16.60
+0.24 (1.47%)
Aug 4, 2026, 3:00 PM CST

SHA:605177 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
305.54243.97513.18711.12501.58556.1
Short-Term Investments
85.4884.9317.83177.9--
Trading Asset Securities
6312050-3050
Cash & Short-Term Investments
454.02448.89581.01889.03531.58606.1
Cash Growth
28.41%-22.74%-34.65%67.24%-12.29%-38.74%
Accounts Receivable
187.56184.79178.1209.59159.39128.89
Other Receivables
6.76.534.761.451.421.65
Receivables
194.26191.33182.85211.03160.81130.54
Inventory
449.6537.18720.57621.06482.84419.33
Prepaid Expenses
----1.08-
Other Current Assets
15.7216.0544.5225.9412.4216.45
Total Current Assets
1,1141,1931,5291,7471,1891,172
Property, Plant & Equipment
1,8691,9001,7441,3521,011834.88
Long-Term Investments
49.9280.69148.28150.64181.4610
Other Intangible Assets
67.359.8760.0661.8562.9745.15
Long-Term Deferred Tax Assets
54.6750.832.8912.5312.910.52
Long-Term Deferred Charges
51.0451.7333.9410.824.313.89
Other Long-Term Assets
32.431.748.098.5910.5174.21
Total Assets
3,2383,3383,5573,3432,4722,251

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
329.11369.77731.77520.12411.09406.25
Accrued Expenses
17.7145.9437.2740.8337.0224.65
Short-Term Debt
190.33228.6298.94120.0795.01-
Current Portion of Long-Term Debt
6.73.779.1-0.02-
Current Portion of Leases
-2.912.983.823.63-
Current Income Taxes Payable
17.295.7606.799.493.64
Current Unearned Revenue
13.4511.9410.363.238.419.41
Other Current Liabilities
22.0522.1923.133.195.025.34
Total Current Liabilities
596.66690.89913.55698.05569.69449.29
Long-Term Debt
777.84752.33677.24576.4315-
Long-Term Leases
6.616.574.86.629.12.38
Long-Term Unearned Revenue
82.2281.8785.8446.236.7140.47
Long-Term Deferred Tax Liabilities
--0.160.460.67-
Other Long-Term Liabilities
0.270.330.270.320.790.85
Total Liabilities
1,4641,5321,6821,328631.95492.99

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
114.72114.73114.75113.6113.6113.6
Additional Paid-In Capital
1,1331,1301,1181,1291,1291,129
Retained Earnings
431.47466.67549.06686.3597.99516.31
Treasury Stock
-20.23-20.29-20.55-30--
Comprehensive Income & Other
115.16114.73113.18116.72-0.48-0.48
Total Common Equity
1,7741,8061,8752,0151,8401,758
Minority Interest
--0.12---
Shareholders' Equity
1,7741,8061,8752,0151,8401,758
Total Liabilities & Equity
3,2383,3383,5573,3432,4722,251

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
981.49994.2793.06706.93122.762.38
Net Cash (Debt)
-527.48-545.31-212.05182.1408.82603.72
Net Cash Growth
----55.46%-32.28%-38.36%
Net Cash Per Share
-4.63-4.77-1.901.463.605.29
Filing Date Shares Outstanding
113.55112.93108.61111.43113.6113.6
Total Common Shares Outstanding
113.55112.93108.61112.58113.6113.6
Working Capital
516.94502.56615.41,049619.04723.13
Book Value Per Share
15.6215.9917.2617.9016.2015.48
Tangible Book Value
1,7071,7461,8151,9531,7771,713
Tangible Book Value Per Share
15.0315.4616.7117.3515.6415.08
Buildings
-1,126632.03545.94454.64410.59
Machinery
-1,4061,1891,084878.92723.64
Construction In Progress
-170.74599.8296.55157.09114.87